Word: benefit
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...belief that there are too many people involved in the futures market. In fact, the opposite is true. The participants are so few that a couple of major players can, if they choose, garner absolute control, cornering the market and creating a price bubble for their own benefit. (Read "Oil Shocks: Biden, Iran and Fears of Another Price Jump...
...What if we took out all the traders who had nothing to do with the oil market? That would leave oil suppliers and oil hedgers: those trying to sell oil and those trying to buy oil, respectively. Suppliers benefit from higher prices and so would not be willing to sell. Hedgers, afraid of soaring prices, would buy oil futures, driving the price to unheard-of levels. Worse still, we would have to worry about the oil suppliers themselves getting in on the futures-price action. They can afford to take on huge risks in the oil-futures market because they...
...Another common misconception is that speculators only buy and hold assets. More accurately, speculators try to benefit from fluctuations in prices. In other words, speculators cannot profit from sustained high prices, only from changing prices. So, yes, the recent volatility in the oil market can certainly be attributed to speculation, but speculation cannot support an extended price rally. Major players like banks, on the other hand, are more than just pure speculators, having the resources to drive prices...
...There is no doubt that the banks and other speculators need accountability and transparency. But smaller speculators - like hedge funds and other trading firms - play a role in maintaining liquidity and reducing the impact that oil suppliers have in participating in the market. Those speculators might benefit from volatility, but without them there would be even more volatility, resulting from radically rising prices. (Read "Black Gold on the Last Frontier...
...have serious side effects. Because it is an immunosuppressant, it can make users susceptible to opportunistic infections. It has also been linked to hyperlipidemia, or high levels of triglycerides in the blood, which can lead to heart disease. It's unclear whether these problems would counteract any longevity benefit that rapamycin might provide in humans. Says Strong, "I think more immediately, people are starting to look at [rapamycin] for age-related diseases like Alzheimer's disease, Parkinson's disease or kidney disease." The drug has also recently entered clinical trials as a human cancer treatment, while another study published last...